Intech Biopharm Corporation (TPEX:6461)
Taiwan
· Delayed Price · Currency is TWD 18.00
-0.05 (-0.28%)
Apr 29, 2026, 1:17 PM CST
Intech Biopharm Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 16.8 | 198.65 | 77.73 | 64.82 | 220.48 | Upgrade
|
| Short-Term Investments | 197.5 | 60 | 520 | 310 | 115 | Upgrade
|
| Cash & Short-Term Investments | 214.3 | 258.65 | 597.73 | 374.82 | 335.48 | Upgrade
|
| Cash Growth | -17.15% | -56.73% | 59.47% | 11.73% | 10.11% | Upgrade
|
| Accounts Receivable | 4.38 | 9.28 | 3.05 | 3.67 | 15.04 | Upgrade
|
| Other Receivables | 2.59 | 9.83 | 8.7 | 7.94 | 7.94 | Upgrade
|
| Receivables | 6.97 | 19.11 | 11.74 | 11.6 | 22.98 | Upgrade
|
| Inventory | 116.48 | 63.86 | 41.53 | 51.82 | 59.87 | Upgrade
|
| Prepaid Expenses | 65.38 | 68.65 | 43.62 | 40.7 | 33.74 | Upgrade
|
| Other Current Assets | - | 0.06 | 0.41 | 0.13 | 4.26 | Upgrade
|
| Total Current Assets | 403.13 | 410.32 | 695.02 | 479.06 | 456.33 | Upgrade
|
| Property, Plant & Equipment | 1,403 | 1,885 | 1,900 | 2,009 | 2,090 | Upgrade
|
| Other Intangible Assets | 4.89 | 3.86 | 4.88 | 4.8 | 4.62 | Upgrade
|
| Long-Term Deferred Tax Assets | 24.77 | 24.77 | 24.77 | 24.77 | 24.77 | Upgrade
|
| Other Long-Term Assets | 514.69 | 71.69 | 86.15 | 33.17 | 26.26 | Upgrade
|
| Total Assets | 2,351 | 2,396 | 2,711 | 2,551 | 2,602 | Upgrade
|
| Accounts Payable | 3.9 | 9.82 | 0.31 | 1.33 | 2.4 | Upgrade
|
| Accrued Expenses | 26.44 | 28.82 | 19.24 | 23.71 | 20.82 | Upgrade
|
| Current Portion of Long-Term Debt | 192.73 | 248.82 | 464.65 | 265.26 | 211.66 | Upgrade
|
| Current Portion of Leases | 0.39 | - | - | - | - | Upgrade
|
| Current Unearned Revenue | 12.94 | 81.18 | 78.54 | 78.31 | 78.99 | Upgrade
|
| Other Current Liabilities | 6.92 | 18 | 5.99 | 5.23 | 9.35 | Upgrade
|
| Total Current Liabilities | 243.32 | 386.64 | 568.73 | 373.82 | 323.22 | Upgrade
|
| Long-Term Debt | 994.9 | 1,188 | 970.41 | 1,143 | 940.77 | Upgrade
|
| Long-Term Leases | 0.6 | - | - | - | - | Upgrade
|
| Long-Term Unearned Revenue | 8.84 | 5.53 | 2.35 | - | - | Upgrade
|
| Pension & Post-Retirement Benefits | 0.85 | - | - | - | - | Upgrade
|
| Long-Term Deferred Tax Liabilities | 0.02 | - | - | - | - | Upgrade
|
| Other Long-Term Liabilities | 1.45 | 1.72 | 1.74 | 1.54 | - | Upgrade
|
| Total Liabilities | 1,250 | 1,582 | 1,543 | 1,519 | 1,264 | Upgrade
|
| Common Stock | 1,784 | 1,379 | 1,374 | 1,170 | 1,163 | Upgrade
|
| Additional Paid-In Capital | 282.09 | 19.76 | 286.16 | 195.15 | 481.32 | Upgrade
|
| Retained Earnings | -959.57 | -579.76 | -488.08 | -327.88 | -301.76 | Upgrade
|
| Comprehensive Income & Other | -5.58 | -5.16 | -4.32 | -5.13 | -4.72 | Upgrade
|
| Shareholders' Equity | 1,101 | 814.28 | 1,168 | 1,032 | 1,338 | Upgrade
|
| Total Liabilities & Equity | 2,351 | 2,396 | 2,711 | 2,551 | 2,602 | Upgrade
|
| Total Debt | 1,189 | 1,436 | 1,435 | 1,409 | 1,152 | Upgrade
|
| Net Cash (Debt) | -974.31 | -1,178 | -837.33 | -1,034 | -816.94 | Upgrade
|
| Net Cash Per Share | -6.42 | -8.58 | -6.95 | -8.90 | -8.03 | Upgrade
|
| Filing Date Shares Outstanding | 178.41 | 137.94 | 137.41 | 116.96 | 116.28 | Upgrade
|
| Total Common Shares Outstanding | 178.41 | 137.94 | 137.41 | 116.96 | 116.28 | Upgrade
|
| Working Capital | 159.81 | 23.68 | 126.3 | 105.24 | 133.11 | Upgrade
|
| Book Value Per Share | 6.17 | 5.90 | 8.50 | 8.82 | 11.50 | Upgrade
|
| Tangible Book Value | 1,096 | 810.42 | 1,163 | 1,027 | 1,333 | Upgrade
|
| Tangible Book Value Per Share | 6.14 | 5.87 | 8.46 | 8.78 | 11.46 | Upgrade
|
| Land | 516.45 | 919.87 | 919.87 | 950.72 | 950.72 | Upgrade
|
| Buildings | 756.97 | 791.07 | 790.24 | 798.32 | 810.2 | Upgrade
|
| Machinery | 754.83 | 724.87 | 657.12 | 645.9 | 633.52 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.